Schisandra lignans-loaded enteric nanoparticles: preparation, characterization, and in vitro–in vivo evaluation

References

• Dai J, Nagai T, Wang X, Zhang T, Meng M, Zhang Q. (2004). pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Int J Pharm, 280, 229–240.
   PubMed Web of Science ®Google Scholar
• De Jaeghere F, Allémann E, Cerny R, Galli B, Steulet AF, Müller I, Schütz H, Doelker E, Gurny R. (2001). pH-Dependent dissolving nano- and microparticles for improved peroral delivery of a highly lipophilic compound in dogs. AAPS PharmSci, 3, E8.
   PubMedGoogle Scholar
• Desai MP, Labhasetwar V, Amidon GL, Levy RJ. (1996). Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res, 13, 1838–1845.
   PubMed Web of Science ®Google Scholar
• Dong WY, Maincent P, Bodmeier R. (2007). In vitro and in vivo evaluation of carbamazepine-loaded enteric microparticles. Int J Pharm, 331, 84–92.
   PubMed Web of Science ®Google Scholar
• Florence AT, Hillery AM, Hussain N. (1995). Nanoparticles as carriers for oral peptide absorption: studies on particle uptake and fate. J Control Rel, 36, 39–46.
   Web of Science ®Google Scholar
• Huang X, Song F, Liu Z, Liu S. (2007). Studies on lignan constituents from Schisandra chinensis (Turcz.) Baill. fruits using high-performance liquid chromatography/electrospray ionization multiple-stage tandem mass spectrometry. J Mass Spectrom, 42, 1148–1161.
   PubMed Web of Science ®Google Scholar
• Huang YJ, Li YB, Yuan HL, Huang X, Wang Q, Xiao XH. (2009). [Preparation of enteric nanoparticles of Schisandra total lignanoids and preliminary study on its pharmacokinetics]. Yao Xue Xue Bao, 44, 1046–1050.
   PubMedGoogle Scholar
• Hussain N, Jaitley V, Florence AT. (2001). Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Deliv Rev, 50, 107–142.
   PubMed Web of Science ®Google Scholar
• Ip SP, Ko KM. (1996). The crucial antioxidant action of schisandrin B in protecting against carbon tetrachloride hepatotoxicity in mice: a comparative study with butylated hydroxytoluene. Biochem Pharmacol, 52, 1687–1693.
   PubMed Web of Science ®Google Scholar
• Ip SP, Poon MK, Che CT, Ng KH, Kong YC, Ko KM. (1996). Schisandrin B protects against carbon tetrachloride toxicity by enhancing the mitochondrial glutathione redox status in mouse liver. Free Radic Biol Med, 21, 709–712.
   PubMed Web of Science ®Google Scholar
• Lee JH, Park TG, Choi HK. (1999). Development of oral drug delivery system using floating microspheres. J Microencapsul, 16, 715–729.
   PubMed Web of Science ®Google Scholar
• Leroux JC, Cozens RM, Roesel JL, Galli B, Doelker E, Gurny R. (1996). pH-sensitive nanoparticles: an effective means to improve the oral delivery of HIV-1 protease inhibitors in dogs. Pharm Res, 13, 485–487.
   PubMed Web of Science ®Google Scholar
• Maurya SK, Bali V, Pathak K. (2012). Bilayered transmucosal drug delivery system of pravastatin sodium: statistical optimization, in vitro, ex vivo, in vivo and stability assessment. Drug Deliv, 19, 45–57.
   PubMed Web of Science ®Google Scholar
• Morgen M, Bloom C, Beyerinck R, Bello A, Song W, Wilkinson K, Steenwyk R, Shamblin S. (2012). Polymeric nanoparticles for increased oral bioavailability and rapid absorption using celecoxib as a model of a low-solubility, high-permeability drug. Pharm Res, 29, 427–440.
   PubMed Web of Science ®Google Scholar
• Mukherjee B, Santra K, Pattnaik G, Ghosh S. (2008). Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers. Int J Nanomedicine, 3, 487–496.
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Rangaswamy V, Aminabhavi TM. (2011). pH-Sensitive oral insulin delivery systems using Eudragit microspheres. Drug Dev Ind Pharm, 37, 977–985.
   PubMed Web of Science ®Google Scholar
• Murakami H, Kobayashi M, Takeuchi H. (2000). Further application of a modified spontaneous emulsification solvent diffusion method to various types of PLGA and PLA polymers for preparation of nanoparticles. Powder Technology, 107, 137–143.
   Web of Science ®Google Scholar
• Nazzal S, Guven N, Reddy IK, Khan MA. (2002). Preparation and characterization of coenzyme Q10-Eudragit solid dispersion. Drug Dev Ind Pharm, 28, 49–57.
   PubMed Web of Science ®Google Scholar
• Opletal L, Sovová H, Bártlová M. (2004). Dibenzo[a,c]cyclooctadiene lignans of the genus Schisandra: importance, isolation and determination. J Chromatogr B Analyt Technol Biomed Life Sci, 812, 357–371.
   PubMed Web of Science ®Google Scholar
• Pan SY, Yu ZL, Dong H (2009). Ethanol extract of fructus schisandrae decreases hepatic triglyceride level in mice fed with a high fat/cholesterol diet, with attention to acute toxicity. Evid Based Complement Altern at Med, 10, 1–6.
   Google Scholar
• Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK, Kumar MN. (2006). Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. J Control Release, 113, 189–207.
   PubMed Web of Science ®Google Scholar
• des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V. (2006). Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release, 116, 1–27.
   PubMed Web of Science ®Google Scholar
• Shah PP, Mashru RC, Rane YM, Thakkar A. (2008). Design and optimization of mefloquine hydrochloride microparticles for bitter taste masking. AAPS PharmSciTech, 9, 377–389.
   PubMed Web of Science ®Google Scholar
• Sigfridsson K, Lundqvist AJ, Strimfors M. (2011). Particle size reduction and pharmacokinetic evaluation of a poorly soluble acid and a poorly soluble base during early development. Drug Dev Ind Pharm, 37, 243–251.
   PubMed Web of Science ®Google Scholar
• Venkateswarlu V, Manjunath K. (2004). Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release, 95, 627–638.
   PubMed Web of Science ®Google Scholar
• Win KY, Feng SS. (2005). Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26, 2713–2722.
   PubMed Web of Science ®Google Scholar
• Yen FL, Wu TH, Lin LT, Cham TM, Lin CC. (2009). Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure. Pharm Res, 26, 893–902.
   PubMed Web of Science ®Google Scholar
• Zaghloul AA, Vaithiyalingam SR, Faltinek J, Reddy IK, Khan MA. (2001). Response surface methodology to obtain naproxen controlled release tablets from its microspheres with Eudragit L100-55. J Microencapsul, 18, 651–662.
   PubMed Web of Science ®Google Scholar